Hudson Bay Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Hudson Bay Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,240	Closed	-$340K	–	648
2019 Q4	$340K	Buy	+14,240	New	+$393K	0.01%	358
2019 Q3	–	Sell	-60,000	Closed	-$1.63M	–	511
2019 Q2	$1.63M	Sell	60,000 -2,500	-4%	-$78.4K	0.04%	294
2019 Q1	$2.17M	Sell	62,500 -37,500	-38%	-$1.08M	0.03%	451
2018 Q4	$1.95M	Sell	100,000 -32,500	-25%	-$668K	0.03%	516
2018 Q3	$3.53M	Buy	132,500 +62,500	+89%	+$2.04M	0.04%	362
2018 Q2	$2.64M	Sell	70,000 -10,000	-13%	-$382K	0.04%	445
2018 Q1	$2.61M	Buy	+80,000	New	+$3.51M	0.05%	397

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Hudson Bay Capital Management's PTLA Position: Q1 2020 in Review

Hudson Bay Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 14,240 shares — an estimated $340K sold.

Hudson Bay Capital Management first reported a position in PTLA in Q1 2018 and held it in 7 quarters. The position peaked at $3.53M in Q3 2018. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Hudson Bay Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 14,240 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $340K.
Hudson Bay Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 7 quarters.
Hudson Bay Capital Management's Portola Pharmaceuticals, Inc. position peaked at $3.53M in Q3 2018.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Hudson Bay Capital Management's 13F filing for Q1 2020, filed 14 May 2020.